Passage Bio Inc.

0.48
-0.04 (-7.34%)
At close: Mar 03, 2025, 3:59 PM
0.48
-0.81%
After-hours: Mar 03, 2025, 04:00 PM EST

Passage Bio Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Net Income -102.06M -136.13M -185.39M -112.23M -45.63M -12.77M
Depreciation & Amortization 3.72M 3.68M 1.54M 800K 134K n/a
Stock-Based Compensation 10.92M 18.95M 32.69M 14.58M 1.45M n/a
Other Working Capital 8.13M -3.08M 9.22M 9.85M -6.74M -8.95M
Other Non-Cash Items 3.82M 3.77M 10.07M 1.26M 952K 2.73M
Deferred Income Tax n/a n/a 2.78M 633K 9.14M n/a
Change in Working Capital 5.34M -8.49M 11.42M 14.44M -5.94M -8.52M
Operating Cash Flow -78.26M -118.21M -126.88M -80.52M -39.9M -18.57M
Capital Expenditures -146K -5.27M -25.64M -1.65M -1.69M -2.54M
Acquisitions n/a 3M 8M 500K n/a n/a
Purchase of Investments -129.43M -157.84M -202.55M -266.06M n/a n/a
Sales Maturities Of Investments 194.81M 188.31M 182.37M 95.6M n/a n/a
Other Investing Acitivies -1 -3M -8M -500K -500 -2.52K
Investing Cash Flow 65.24M 25.2M -45.81M -172.11M -1.69M -2.54M
Debt Repayment n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a -1.35M -37K 284K 175.6M 45.97M
Financial Cash Flow 135K -1.35K 166.66K 228.75M 175.6M 45.97M
Net Cash Flow -12.89M -94.36M -6.04M -23.87M 134.01M 24.86M
Free Cash Flow -78.41M -123.48M -152.52M -82.17M -41.59M -21.11M